Research is looking into the distinct possibility that there may be a tumor marker in the blood of those with ovarian cancer . Early diagnosis of this cancer can be very difficult. As it advances it becomes harder and harder to treat. New research hopes the answers are in the blood.
The research is taking place in Chicago at the Rush University Medical Center. Initial research was intriguing though additional studies are required before anything is certain.
Antibodies, found on the surface of ovarian cancer cells, were found in the blood of most of the women with ovarian cancer. These antibodies were also found with women who had previously known ovarian problems - but not necessarily cancer. Women with normal ovarian function and no ovarian cancer were found to not have this antibody.
Typical treatment of ovarian cancer is to removed the uterus completely. This is usually done because the cancer is in an advanced stage. Single ovary removal along with the fallopian tubes can also be seen. Following surgery chemotherapy is a possibility. Radiation is rarely used as a treatment.
If the cancer is diagnosed early - the fiver year survival is very high. If not, the survival rate is far lower.
